The Andhra Pradesh MedTech Zone (AMTZ) has completed a major upgrade and expansion of its Additive Manufacturing Centre of Excellence, positioning it as one of the most advanced shared facilities for medical 3D printing in India. The enhanced centre, made operational in January 2026, introduces state-of-the-art capabilities that address critical gaps in domestic manufacturing of high-precision, patient-specific medical devices.

The upgraded AM CoE now includes:

Industrial-grade multi-material polymer 3D printers for anatomical models and surgical guides

Metal additive manufacturing systems (laser powder bed fusion) for titanium and cobalt-chrome implants

Bioprinting platforms for tissue engineering and regenerative medicine research

Advanced post-processing suites (vapour smoothing, heat treatment, sterilisation validation)

A regulatory and quality compliance lab equipped for ISO 13485, US FDA, and CE marking support

Dedicated CAD/CAM workstations and simulation software for design optimisation

The facility operates on a shared-economy model, allowing medtech startups, MSMEs, and large manufacturers to access world-class additive manufacturing without heavy upfront capital investment. AMTZ provides end-to-end support from design consultation and material selection to prototyping, validation, and regulatory documentation helping companies move from concept to commercial production faster and more cost-effectively.

The expansion is expected to play a pivotal role in localising production of complex, high-value devices such as custom cranial implants, orthopaedic trauma plates, dental prosthetics, hearing aid shells, and patient-matched surgical instruments. By enabling rapid prototyping and small-batch customisation, the centre reduces lead times from months to weeks and cuts costs significantly compared to imported equivalents.

Dr. Jitendra Sharma, Managing Director & CEO of AMTZ, stated: “Additive manufacturing is a game-changer for medtech it allows us to create patient-specific solutions that were previously impossible or prohibitively expensive in India. By scaling this centre, we are empowering our startups and manufacturers to compete globally while making advanced devices more accessible to Indian patients.”

The initiative aligns with the Government of India’s Atmanirbhar Bharat and Make-in-India campaigns, particularly the push to increase domestic value addition in medical devices from the current ~20–30% to over 70% in high-technology segments. AMTZ is also partnering with academic institutions and global technology providers to train engineers, technicians, and designers in medical 3D printing, creating a skilled talent pool for the sector.

Early adopters from the Indian medtech startup ecosystem have already begun utilising the expanded facility for prototyping orthopaedic implants, dental aligners, and custom surgical tools, with several products advancing toward regulatory clearance and commercial launch in 2026–2027.